- Home
- Publications
- Publication Search
- Publication Details
Title
Disease-modifying anti-asthmatic drugs
Authors
Keywords
-
Journal
LANCET
Volume 399, Issue 10335, Pages 1664-1668
Publisher
Elsevier BV
Online
2022-04-22
DOI
10.1016/s0140-6736(22)00331-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Biologic Therapies for Severe Asthma
- (2022) Guy G. Brusselle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Selecting Endpoints for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT consensus from the IOIBD
- (2021) Catherine Le Berre et al. GASTROENTEROLOGY
- The basic immunology of asthma
- (2021) Hamida Hammad et al. CELL
- STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
- (2021) Dan Turner et al. GASTROENTEROLOGY
- Triple vs Dual Inhaler Therapy and Asthma Outcomes in Moderate to Severe Asthma
- (2021) Lisa H. Y. Kim et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2021) Joseph K Han et al. Lancet Respiratory Medicine
- One Hundred Ten Years of Allergen Immunotherapy: A Broad Look Into the Future
- (2021) Oliver Pfaar et al. Journal of Allergy and Clinical Immunology-In Practice
- Type 2 biomarker expression (FeNO and blood eosinophils) is higher in severe adult‐onset than in severe early‐onset asthma
- (2021) Marek Lommatzsch et al. ALLERGY
- Ibrutinib induces durable remissions in treatment-naïve patients with CLL and 17p deletion/TP53 mutations
- (2021) Mariela Sivina et al. BLOOD
- 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2021) Theresa A McDonagh et al. EUROPEAN HEART JOURNAL
- Stopping versus continuing long-term mepolizumab treatment in severe eosinophilic asthma (COMET study)
- (2021) Wendy C. Moore et al. EUROPEAN RESPIRATORY JOURNAL
- Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial
- (2021) Brian G Feagan et al. LANCET
- Defining a Severe Asthma Super-Responder: Findings from a Delphi Process
- (2021) John W. Upham et al. Journal of Allergy and Clinical Immunology-In Practice
- Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes
- (2021) Helen K. Reddel et al. EUROPEAN RESPIRATORY JOURNAL
- Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study
- (2021) Michael E Wechsler et al. Lancet Respiratory Medicine
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
- (2020) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis
- (2020) Alexandre Sepriano et al. ANNALS OF THE RHEUMATIC DISEASES
- Real-World Effectiveness and the Characteristics of a “Super-Responder” to Mepolizumab in Severe Eosinophilic Asthma
- (2020) Joanne E. Kavanagh et al. CHEST
- Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials
- (2020) Philippe Gevaert et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Immune Modulation in Asthma: Current Concepts and Future Strategies
- (2020) Marek Lommatzsch RESPIRATION
- Once-daily mometasone plus indacaterol versus mometasone or twice-daily fluticasone plus salmeterol in patients with inadequately controlled asthma (PALLADIUM): a randomised, double-blind, triple-dummy, controlled phase 3 study
- (2020) Richard N van Zyl-Smit et al. Lancet Respiratory Medicine
- Once-daily, single-inhaler mometasone–indacaterol–glycopyrronium versus mometasone–indacaterol or twice-daily fluticasone–salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study
- (2020) Huib A M Kerstjens et al. Lancet Respiratory Medicine
- Personalized medicine for allergy treatment: Allergen immunotherapy still a unique and unmatched model
- (2020) Cristoforo Incorvaia et al. ALLERGY
- Real World Effectiveness of Benralizumab in Severe Eosinophilic Asthma
- (2020) Joanne E. Kavanagh et al. CHEST
- Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial
- (2020) Laurie A Lee et al. Lancet Respiratory Medicine
- More options for managing severe asthma in adults
- (2020) Anne B Chang et al. Lancet Respiratory Medicine
- Composite type-2 biomarker strategy versus a symptom–risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial
- (2020) Liam G Heaney et al. Lancet Respiratory Medicine
- Long-term therapy response to anti-interleukin-5 biologics in severe asthma – a real-life evaluation
- (2020) Katrien Eger et al. Journal of Allergy and Clinical Immunology-In Practice
- The Relationship of Asthma Biologics to Remission for Asthma
- (2020) Andrew Menzies-Gow et al. Journal of Allergy and Clinical Immunology-In Practice
- Short- and long-term real-world effectiveness of omalizumab in severe allergic asthma: systematic review of 42 studies published 2008-2018
- (2019) Karen M. MacDonald et al. Expert Review of Clinical Immunology
- Oral corticosteroid use, morbidity, and mortality in asthma: a nationwide prospective cohort study in Sweden
- (2019) Magnus Ekström et al. ALLERGY
- The Cytokines of Asthma
- (2019) Bart N. Lambrecht et al. IMMUNITY
- GINA 2019: a fundamental change in asthma management
- (2019) Helen K. Reddel et al. EUROPEAN RESPIRATORY JOURNAL
- Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
- (2019) Claus Bachert et al. LANCET
- Single inhaler extrafine triple therapy in uncontrolled asthma (TRIMARAN and TRIGGER): two double-blind, parallel-group, randomised, controlled phase 3 trials
- (2019) Johann Christian Virchow et al. LANCET
- An expert consensus framework for asthma remission as a treatment goal
- (2019) Andrew Menzies-Gow et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
- (2018) Michael Hallek et al. BLOOD
- Asthma
- (2018) Alberto Papi et al. LANCET
- After asthma: redefining airways diseases
- (2018) Ian D Pavord et al. LANCET
- A randomized multicenter study evaluating Xolair persistence of response after long-term therapy
- (2017) Dennis Ledford et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers
- (2017) Mohamed H. Shamji et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Novel treatment strategies in rheumatoid arthritis
- (2017) Gerd R Burmester et al. LANCET
- Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
- (2017) Andrew Blauvelt et al. LANCET
- Managing asthma in the era of biological therapies
- (2017) Philip G Bardin et al. Lancet Respiratory Medicine
- Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma
- (2016) J. Christian Virchow et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Eosinophils in the Spotlight: Eosinophilic airway inflammation in nonallergic asthma
- (2013) Guy G Brusselle et al. NATURE MEDICINE
- Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria
- (2013) Marcus Maurer et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Patient with Asthma Seeks Medical Advice in 1828, 1928, and 2012
- (2012) Erika von Mutius et al. NEW ENGLAND JOURNAL OF MEDICINE
- American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials
- (2011) D. T. Felson et al. ANNALS OF THE RHEUMATIC DISEASES
- Remission of asthma: The next therapeutic frontier?
- (2011) John W. Upham et al. PHARMACOLOGY & THERAPEUTICS
- Long-lasting effects of sublingual immunotherapy according to its duration: A 15-year prospective study
- (2010) Maurizio Marogna et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Mechanisms of adverse effects of -agonists in asthma
- (2009) S. L Johnston et al. THORAX
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started